Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
Varda Space Industries raises a $251M Series D, valuing it at $1.6B, to advance space-based drug manufacturing using low ...
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Beam Therapeutics sued YolTech's Yuxuan Wu & Zi Jun Wang and Serapha Bio for allegedly stealing trade secrets related to ...
Zealand and Roche's petrelintide peaks at 10.7% weight loss at its middle dose in Ph2, trailing Lilly's eloralintide at 20.1% ...
UniQure's shares were rocked Tuesday morning after the company revealed its experimental Huntington’s disease gene therapy ...
NCI director Ned Sharpless as MD and Andrew Witty as chairman, while raising a $100M second opportunities fund.
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
Former House majority leader Eric Cantor has been chosen as PhRMA’s next CEO, according to two sources familiar ...
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
Ex-Genentech AI leaders including NYU's Kyunghyun Cho launch health startup Ortet with a $500M commitment from Matt Holt's ...
At the end of 2027, BioNTech will exit factories in Idar-Oberstein and Marburg and a site in Tübingen that was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results